A short history of platelet glycoprotein Ib complex

Thrombosis and Haemostasis

Volumn 98, Issue 1, 2007, Pages 63-68

  Clementson, Kenneth J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 8; CALMODULIN; CD11B ANTIGEN; CD36 ANTIGEN; COLLAGEN; FIBRINOGEN; FILAMIN; GLYCOCALICIN; GLYCOPROTEIN IB; GLYCOPROTEIN IB ALPHA; GLYCOPROTEIN VI; HIGH MOLECULAR WEIGHT KININOGEN; LACTOPEROXIDASE; PADGEM PROTEIN; PERIODATE; PROTEINASE ACTIVATED RECEPTOR; RISTOCETIN; THROMBIN; THROMBOSPONDIN 1; VON WILLEBRAND FACTOR;

ARTICLE; BERNARD SOULIER DISEASE; BINDING SITE; CROSSED IMMUNOELECTROPHORESIS; DNA SEQUENCE; GEL ELECTROPHORESIS; GLANZMANN DISEASE; GLYCOSYLATION; HUMAN; MOLECULAR CLONING; NONHUMAN; PHASE SEPARATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; TWO DIMENSIONAL ELECTROPHORESIS;

BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; LIGANDS; MULTIPROTEIN COMPLEXES; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; THROMBIN;

EID: 34447529128     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-05-0327     Document Type: Article

References (107)

1. Dodgson CL. Alice's Adventures in Wonderland. London: Macmillan and Co.; 1865.
2. Bernard J, Soulier JP. Sur une nouvelle variété de dystrophie thrombocytaire-hémorragipare congénitale. Semin Hôp Paris 1948; 24: 3217-3223.
3. Nurden AT, Caen JP. Specific roles for platelet surface glycoproteitis in platelet function. Nature 1975; 255: 720-722.
4. Clemetson KJ, et al. Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. J Clin Invest 1982; 70: 304-311.
5. Grottum KA, Solum NO. Congenital thrombocytopenia with giant platelets: a defect in the platelet membrane. Br J Haematol 1969; 16: 277-290.
6. Donati MB, de Gaetano GJV. Evidence that bovine factor VIII, not bovine fibrinogen, aggregates human platelets. Thromb Res 1973; 2: 97-103.
7. Pepper DS, Jamieson GA. Studies on glycoproteins. 3. Isolation of sialylglycopeptides from human platelet membranes. Biochemistry 1969; 8: 3362-3369.
8. Bithell TC, et al. Platelet-function studies in the Bernard-Soulier syndrome. Ann NY Acad Sci 1972; 201: 145-160.
9. Weiss HJ, et al. Decreased adhesion of giant (Bernard-Soulier) platelets to subendothelium. Further implications on the role of the von Willebrand factor in hemostasis. Am J Med 1974; 57: 920-925.
10. Howard MA, Firkin BG. Ristocetin - a new tool in the investigation of platelet aggregation. Thromb Diath Haemorrh 1971; 26: 362-369.
11. Nachman RL, Ferris B. Studies on the proteins of human platelet membranes. J Biol Chem 1972; 247: 4468-4475.
12. Phillips DR. Effect of trypsin on the exposed polypeptides and glycoproteins in the human platelet membrane. Biochemistry 1972; 11: 4582-4588.
13. Phillips DR, et al. Molecular differences of exposed surface proteins on thrombasthenic platelet plasma membranes. Nature 1975; 257: 599-600.
14. Jenkins CS, et al. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease. J Clin Invest 1976; 57: 112-124.
15. Phillips DR, Agin PP. Platelet plasma membrane glycoproteins. Evidence for the presence of nonequivalent disulfide bonds using nonreduced-reduced two-dimensional gel electrophoresis. J Biol Chem 1977; 252: 2121-2126.
16. Andersson LC, Gahmberg CG. Surface glycoproteins of human white blood cells. Analysis by surface labeling. Blood 1978; 52: 57-67.
17. Solum NO, et al. Human platelet glycoproteins. Further evidence that the "GP I band" from whole platelets contains three different polypeptides one of which may be involved in the interaction between platelets and factor VIII. Thromb Res 1977; 10: 71-82.
18. Solum NO, et al. Platelet membrane glycoproteins and the interaction between bovine factor VIII related protein and human platelets. Thromb Haemost 1977; 38: 914-923.
19. Clemetson KJ, et al. Relationship between glycocalicin and glycoprotein Ib of human platelets. Proc Nad Acad Sci USA 1981; 78: 2712-2716.
20. Nachman RL, et al. Wheat germ agglutinin affinity chromatography of human platelet membrane glycoproteins. Thromb Res 1978; 12: 91-104.
21. Okumura T, et al. Platelet glycocalicin. Interaction with thrombin and role as thrombin receptor of the platelet surface. J Biol Chem 1978; 253: 3435-3443.
22. Berndt MC, Phillips DR. Purification and preliminary physicochemical characterization of human plateletmembrane glycoprotein V. J Biol Chem 1981; 256: 59-65.
23. Ganguly P. Binding of thrombin to functionally defective platelets: a hypothesis on the nature of the thrombin receptor. Br J Haematol 1977; 37: 47-51.
24. Coller BS, et al. Studies with a murine monoclonal antibody that abolishes ristocetin- induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Wittebrand factor. Blood 1983; 61: 99-110.
25. Sakariassen KS, et al. A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J Lab Clin Med 1983; 102: 522-535.
26. Sakariassen KS, et al. The role of platelet membrane glycoproteins Ib and IIb-IIIa in platelet adherence to human artery subendothelium. Br J Haematol 1986; 63: 681-691.
27. Clemetson KJ, et al. Distribution of platelet glycoproteins and phosphoproteins in hydrophobic and hydrophilic phases in Triton X-114 phase partition. Biochim Biophys Acta 1984; 778: 463-469.
28. Du X, et al. Glycoprotcin Ib and glycoprotein IX are fully complexed in the intact platelet membrane. Blood 1987; 69: 1524-1527.
29. Modderman PW, et al. Glycoproteins V and Ib-IX form a noncovalent complex in the platelet membrane. J Biol Chem 1992; 267: 364-369.
30. Luo S-Z, et al. Glycoprotein Ib forms disulfide bonds with 2 glycoprotein Ibb subunits in the resting platelet. Blood 2007; 109: 603-609.
31. Wicki AN, Clemetson KJ. Structure and function of platelet membrane glycoproteins Ib and V Effects of leukocyte elastase and other proteases on platelets response to von Willebrand factor and thrombin. Eur J Biochern 1985; 153: 1-11.
32. Wyler B, et al. Glycoprotein Ibβ is the only phosphorylated major membrane glycoprotein in human platelets. Biochem J 1986; 234: 373-379.
33. Wardell MR, et al. Platelet glycoprotcin Ibβ is phosphorylated on serine 166 by cyclic AMP-dependent protein kinase. J Biol Chem 1989; 264: 15656-15661.
34. Judson PA, et al. Isolation and characterization of the major oligosaccharide of human platelet membrane glycoprotein GPIb. Biochern J 1982; 205: 81-90.
35. Korrel SA, et al. Structural studies on the O-linked carbohydrate chains of human platelet glycocalicin. Eur J Biochem 1984; 140: 571-576.
36. Tsuji T, et al. The carbohydrate moiety of human platelet glycocalicin. J Biol Chem 1983; 258: 6335-6339.
37. Lopez JA, et al. Cloning of the alpha chain of human platelet glycoprotein Ib: a transmembrane protein with homology to leucine-rich α2-glycoprotein. Proc Natl Acad Sci USA 1987; 84: 5615-5619.
38. Lopez JA, et al. The alpha and beta chains of human platelet glycoprotein Ib: are both transmernbrane proteins containing a leucine-rich amino acid sequence. Proc Natl Acad Sci USA 1988; 85: 2135-2139.
39. Hickey MJ, et al. Human platelet glycoprotein IX: an adhesive prototype of leucine-rich glycoproteins with flank-center-flank structures. Proc Natl Acad Sci USA 1989; 86: 6773-6777.
40. Brinkhous KM, et al. Botrocetin (venom coagglutinin): reaction with a broad spectrum of multimeric forms of factor VIII macromolecular complex. Proc Natl Acad Sci USA 1983; 80: 1463-1466.
41. Wicki AN, et al. Isolation and characterization of human blood platelet mRNA and construction of a cDNA library in λgt11. Confirmation of the platelet derivation by identification of GPIb coding mRNA and cloning of a GPIb coding cDNA insert. Thromb Haemost 1989; 61: 448-453.
42. Wenger RH, et al. The 5′ flanking region and chromosomal localization of the gene encoding human platelet membrane glycoprotein Ibα Gene 1989; 85: 517-524.
43. Muszbek L, Laposata M. Glycoprotein Ib and glycoprotein IX in human platelets are acylated with palmitic acid through thioester linkages. J Biol Chem 1989; 264: 9716-9719.
44. Miller JL, et al. Mutation in the gene encoding the a chain of platelet glycoprotein Ib in platelet-type von Willebrand disease. Proc Natl Acad Sci USA 1991; 88: 4761-4765.
45. Russell SD, Roth GJ. Pseudo-von Willebrand discase: A mutation in the platelet glycoprotein Ibα gene associated with a hyperactive surface receptor. Blood 1993; 81: 1787-1791.
46. Hourdille P, et al. Thrombin induces a rapid redistribution of glycoprotein Ib-IX complexes within the membrane systems of activated human platelets. Blood 1990; 76: 1503-1513.
47. Peng M, et al. Alboaggregin-B: A new platelet agonist that binds to platelet membrane glycoprotein Ib. Biochemistry 1991; 30: 11529-11536.
48. Peng M, et al. Characterization of three alboaggregins purified from Trimeresurus albolabris venom. Thromb Haemost 1992; 67: 702-707.
49. Kroll MH, et al. von Willebrand factor binding to platelet GP1b initiates signals for platelet activation. J Clin Invest 1991; 88: 1568-1573.
50. Hess D, et al. Identification of the disulphide bonds in human platelet glycocalicin. Eur J Biochem 1991; 199: 389-393.
51. Aakhus AM, et al. Glycoprotein Ib- and actin-binding regions in human platelet actin-binding protein. Biochem Soc Trans 1991; 19: 1133-1134.
52. Andrews RK, Fox JEB. Interaction of purified actin-binding protein with the platelet membrane glycoprotein Ib-IX complex. J Biol Chem 1991; 266: 7144-7147.
53. Beer JH, et al. Glycocalicin: A new assay - The normal plasma levels and its potential usefulness in selected diseases. Blood 1994; 83: 691-702.
54. Wu G, et al. Human endothelial cells in culture and in vivo express on their surface all four components of the glycoprotein Ib/IX/V complex. Blood 1997; 90: 2660-2669.
55. Miller JL, et al. Mutation of leucine-57 to phenylalanine in a platelet glycoprotein Ibα leucine tandem repeat occurring in patients with an autosomal dominant variant of Bernard-Soulier disease. Blood 1992; 79: 439-446.
56. Lanza F, et al. Cloning and characterization of the gene encoding the human platelet glycoprotein V. A member of the leucine-rich glycoprotein family cleaved during thrombin-induced platelet activation. J Biol Chem 1993; 268: 20801-20807.
57. Peng M, et al. Echicetin: A snake venom protein that inhibits binding of von Willebrand factor and alboaggregins to platelet glycoprotein Ib. Blood 1993; 81: 2321-2328.
58. Lu Q, et al. Snake venom C-type lectins interacting with platelet receptors. Structure-function relationships and effects on haemostasis. Toxicon 2005; 45: 1089-1098.
59. Wright SD, et al. Double heterozygosity for mutations in the platelet glycoprotein IX gene in three siblings with Bernard-Soulier syndrome. Blood 1993; 81: 2339-2347.
60. Clemetson JM, et al. Variant Bernard-Soulier syndrome associated with a homozygous mutation in the leucine-rich domain of glycoprotein IX Blood 1994; 84: 1124-1131.
61. Du X, et al. Identification of a binding sequence for the 14-3-3 protein within the cytoplasmic domain of the adhesion receptor, platelet glycoprotein Ib alpha. J Biol Chem 1996; 271: 7362-7367.
62. López JA, et al. Polymorphism of human glycoprotein Ibα results from a variable number of tandem repeats of a 13-amino acid sequence in the mucin-like macroglycopeptide region. Structure/function implications. J Biol Chem 1992; 267: 10055-10061.
63. Dong JF, et al. Tyrosine sulfation of the glycoprotein Ib-IX complex: identification of sulfated residues and effect on ligand binding. Biochemistry 1994; 33: 13946-13953.
64. Ward CM, et al. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein lba as a binding site for von Willebrand factor and α-thrombin. Biochemistry 1996; 35: 4929-4938.
65. Ludlow LB, et al. Identification of a mutation in a GATA binding site of the platelet glycoprotein Ibβ promoter resulting in the Bernard-Soulier syndrome. J Biol Chem 1996; 271: 22076-22080.
66. Bastian LS, et al. Analysis of the megakaryocyte glycoprotein IX promoter identifies positive and negative regulatory domains and functional GATA and Ets sites. J Biol Chem 1996; 271: 18554-18560.
67. Ozaki Y, et al. Protein tyrosine phosphorylation in human platelets induced by interaction between glycoprotein Ib and von Willebrand factor. Biochim Biophys Acta 1995; 1243: 482-488.
68. Sullam PM, et al. Physical proximity and functional interplay of the glycoprotein Ib-IX-V complex and the Fc receptor FcγRIIA on the platelet plasma membrane. J Biol Chem 1998; 273: 5331-5336.
69. Yuan Y, et al. The von Willebrand factor-glycoprotein Ib/V/IX interaction induces actin polymerization and cytoskeletal reorganization in rolling platelets and glycoprotein Ib/V/IX-transfected cells. J Biol Chem 1999; 274: 36241-36251.
70. Bodnar RJ, et al. The cytoplasmic domain of the platelet glycoprotein Ibα is phosphorylated at serine 609. J Biol Chem 1999; 274: 33474-33479.
71. Romo GM, et al. The glycoprotein Ib-IX-V complex is a platelet counter receptor for P-selectin. J Exp Med 1999; 190: 803-814.
72. Falati S, et al. Glycoprotein Ib-V-IX, a receptor for von Willebrand factor, couples physically and functionally to the Fc receptor gamma-chain, Fyn, and Lyn to activate human platelets. Blood 1999; 94: 1648-1656.
73. Beguin S, et al. Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor. Blood 1999; 93: 564-570.
74. Dormann D, et al. The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity. Blood 2000; 96: 2469-2478.
75. Soslau G, et al. Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib. J Biol Chem 2001; 276: 21173-21183.
76. Simon DI, et al. Platelet glycoprotein Ibα is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med 2000; 192: 193-204.
77. Ware J, et al. Generation and rescue of a murine model of platelet dysfunction: the Bemard-Soulier syndrome. Proc Natl Acad Sci USA 2000; 97: 2803-2808.
78. Williamson D, et al. Interaction between platelet glycoprotein lba and filamin-1 is essential for glycoprotein Ib/IX receptor anchorage at high shear. J Biol Chem 2002; 277: 2151-2159.
79. Englund GD, et al. Regulation of von Willebrand factor binding to the platelet glycoprotein Ib-IX by a membrane skeleton-dependent inside-out signal. J Biol Chem 2001; 276: 16952-16959.
80. Ramakrishnan V, et al. Increased thrombin responsiveness in platelets from mice lacking glycoprotein V Proc Natl Acad Sci USA 1999; 96: 13336-13341.
81. Ni H, et al. Increased thrombogenesis and embolus formation in mice lacking glycoprotein V. Blood 2001; 98: 368-373.
82. Kahn ML, et al. Glycoprotein V-deficient platelets have undiminished thrombin responsiveness and do not exhibit a Bernard-Soulier phenotype. Blood 1999; 94: 4112-4121.
83. Moog S, et al. Platelet glycoprotein V binds to collagen and participates in platelet adhesion and aggregation. Blood 2001; 98: 1038-1046.
84. Baker J, et al. GPIb potentiates GPVI-induced responses in human platelets. Platelets. 2004; 15: 207-214.
85. Dormann D, et al. Alboaggregin A activates platelets by a mechanism involving glycoprotein VI as well as glycoprotein Ib. Blood 2001; 97: 929-936.
86. De Candia E, et al. Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets. J Biol Chem 2001; 276: 4692-4698.
87. Uff S, et al. Crystal structure of the platelet glycoprotein Ibalpha N-terminal domain reveals an unmasking mechanism for receptor activation. J Biol Chem 2002; 277: 35657-35663.
88. Huizinga EG, et al. Structures of glycoprotein Ibα and its complex with von Willebrand factor A1 domain. Science 2002; 297: 1176-1179.
89. Dumas JJ, et al. Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibα complex reveals conformation differences with a complex bearing von Willebrand disease mutations. J Biol Chem 2004; 279: 23327-23334.
90. Dumas JJ, et al. Crystal structure of the GpIba-thrombin complex essential for platelet aggregation. Science 2003; 301: 222-226.
91. Celikel R, et al. Modulation of α-thrombin function by distinct interactions with platelet glycoprotein Ibα. Science 2003; 301: 218-221.
92. Dopheide SM, et al. Shear-dependent tether formation during platelet translocation on von Willebrand factor. Blood 2002; 99: 159-167.
93. Reininger AJ, et al. Mechanism of platelet adhesion to von Willebrand factor and microparticle formation underhigh shear stress. Blood 2006; 107: 3537-3545.
94. Hoffmeister KM, et al. The clearance mechanism of chilled blood platelets. Cell 2003; 112: 87-97.
95. Hoffmeister KM, et al. Glycosylation restores survival of chilled blood platelets. Science 2003; 301: 1531-1534.
96. Jin W, et al. A role for glycosphingolipid-enriched microdomains in platelet glycoprotein Ib-mediated platelet activation. J Thromb Haemost 2007; 5: 1034-1040.
97. Andrews RK, et al. Interaction of calmodulin with the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX-V complex. Blood 2001; 98: 681-687.
98. Arthur IF, et al. Glycoprotein VI is associated with GPIb-IX-V on the membrane of resting and activated platelets. Thromb Haemost 2005; 93: 716-723.
99. Jurk K, et al. Thrombospondin-1 mediates platelet adhesion at high shear via glycoprotein Ib (GPIb): an altemative/backup mechanism to von Willebrand factor. FASEB J 2003; 17: 1490-1492.
100. Baglia FA, et al. Factor XI interacts with the leucine-rich repeats of glycoprotein Ibα on the activated platelet. J Biol Chem 2004; 278: 48112-48119.
101. Bradford HN, et al. Human factor XII binding to the glycoprotein Tb-IX-V complex inhibits thrombin-induced platelet aggregation. J Biol Chem 2000; 275: 22756-22763.
102. Bradford HN, et al. Human kininogens regulate thrombin binding to platelets through the glycoprotein Ib-IX-V complex. Blood 1997; 90: 1508-1515.
103. Chavakis T, et al. High molecular weight kininogen regulates platelet-leukocyte interactions by bridging Mac-1 and glycoprotein Ib. J Biol Chem 2003; 278: 45375-45381.
104. Bergineier W, et al. The role of platelet adhesion receptor GPIbalpha far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis. Proc Natl Acad Sci USA 2006; 103: 16900-16905.
105. Ozaki Y, et al. Platelet GPIb-IX-V-dependent signaling. J Thromb Haemost 2005; 3: 1745-1751.
106. Du X. Signaling and regulation of the platelet glycoprotein Ib-IX-V complex. Curr Opin Hematol 2007; 14: 262-269.
107. Canobbio I, et al. Signalling through the platelet glycoprotein Ib-V-IX complex. Cell Signal 2004; 16: 1329-1344.